Le Lézard
Classified in: Business
Subject: ATY

BAK Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Braskem S.A. Shareholders of Class Action and Lead Plaintiff Deadline: October 26, 2020


NEW YORK, Aug. 27, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Braskem S.A. ("Braskem" or "the Company") (NYSE: BAK) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Braskem securities between May 6, 2016, and July 8, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/bak

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. 

The Complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Braskem's salt mining operations were unsafe and presented a significant danger to surrounding areas, including nearly two thousand properties; (2) the foregoing foreseeably increased the risk that Braskem would be subjected to remedial liabilities, including, but not limited to, increased governmental and/or regulatory oversight or enforcement, significant monetary and reputational damage, and/or the permanent closure of one or more of its salt mining operations; (3) accordingly, earnings generated from Braskem's salt mining operations were unsustainable; (4) Braskem downplayed the true scope and severity of the Company's liability with respect to its salt mining operations; and (5) as a result, the Company's public statements were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/bak or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Braskem you have until October 26, 2020 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE Bronstein, Gewirtz & Grossman, LLC


These press releases may also interest you

at 16:36
Dunkin' Brands Group, Inc., , the parent company of two of the world's most recognized brands, Dunkin' and Baskin-Robbins, confirms that it has held preliminary discussions to be acquired by Inspire Brands. There is no certainty that any agreement...

at 15:49
Current Cloud Backlog of ?6.6 Billion, Up 16% At Constant Currencies IFRS Cloud Gross Margin Up 1.8pp; Non-IFRS Cloud Gross Margin Up 0.7pp At Constant Currencies IFRS Operating Margin Down 2.2pp; Non-IFRS Operating Margin Up 1.3pp At Constant...

at 14:05
Celanese Corporation , a global chemical and specialty materials company, today reported third quarter GAAP diluted earnings per share of $1.76 and adjusted earnings per share of $1.95. The Company recorded net sales of $1.4 billion driven by 20...

at 13:00
Blue Butterfly, a strategic consultancy for the retail real estate industry, announces the appointment of Christie Sparks as Director, Business Development. Sparks will support business development on behalf of clients as well as client acquisition...

at 12:10
Totaling a recently-purchased car is an extremely unpleasant situation. The insurance company will pay only the Actual Cash Value. Cars lose a significant portion of their value as soon as they leave the lot. The owner may be reimbursed with less...

at 10:45
Mirati Therapeutics, Inc. , a clinical-stage targeted oncology company, today announced preliminary results from the Company's mutant KRAS selective inhibitor programs. The preliminary results included updated clinical data of adagrasib (MRTX849),...



News published on 27 august 2020 at 17:31 and distributed by: